Epstein-barr virus infection and multiple sclerosis: A review

Journal of Neuroimmune Pharmacology

Volumn 5, Issue 3, 2010, Pages 271-277

  Ascherio, Alberto ^a   Munger, Kassandra L ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epstein Barr virus; infection; multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; VIRUS ANTIBODY;

B LYMPHOCYTE; BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HODGKIN DISEASE; HOST CELL; HUMAN; IMMUNE SYSTEM; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; NASOPHARYNX CARCINOMA; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS CARCINOGENESIS;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS; NEOPLASMS; RISK FACTORS;

EID: 77955982402     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-010-9201-3     Document Type: Review

References (73)

1. C Ahlgren, et al. 2009 A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk Eur J Epidemiol 24 9 541 552 10.1007/s10654-009-9367-2 19633994
2. S Alotaibi, et al. 2004 Epstein-Barr virus in pediatric multiple sclerosis JAMA 291 15 1875 1879 10.1001/jama.291.15.1875 1:CAS:528: DC%2BD2cXjsVajsbs%3D 15100207
3. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 4 288 299 10.1002/ana.21117 17444504
4. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part II: noninfectious factors Ann Neurol 61 6 504 513 10.1002/ana.21141 1:CAS:528:DC%2BD2sXptFGhtLc%3D 17492755
5. Ascherio A, Munger KL (2010) Epidemiology of multiple sclerosis: environmental factors, In: Luchinetti and Hohlfeld, eds. Multiple Sclerosis 3, 1st ed. Philadelphia: Saunders, Elsevier 57-82. Copyright © 2010 Elsevier. All rights reserved
6. A Ascherio, et al. 2001 Epstein-barr virus antibodies and risk of multiple sclerosis: a prospective study JAMA 286 24 3083 3088 10.1001/jama.286.24.3083 1:CAS:528:DC%2BD38XhsFaqug%3D%3D 11754673
7. JF Bach 2002 The effect of infections on susceptibility to autoimmune and allergic diseases N Engl J Med 347 12 911 920 10.1056/NEJMra020100 12239261
8. B Banwell, et al. 2007 Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study Lancet Neurol 6 9 773 781 10.1016/S1474-4422(07)70196-5 17689148
9. E Bech, et al. 2002 A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS Neurology 58 1 31 36 1:CAS:528:DC%2BD38XnsVyltA%3D%3D 11781402
10. D Buljevac, et al. 2005 Epstein-Barr virus and disease activity in multiple sclerosis J Neurol Neurosurg Psychiatry 76 10 1377 1381 10.1136/jnnp.2004.048504 1:STN:280:DC%2BD2MvpslyitA%3D%3D 16170080
11. S Cepok, et al. 2005 Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis J Clin Invest 115 5 1352 1360 1:CAS:528:DC%2BD2MXktFSktLY%3D 15841210
12. ET Chang HO Adami 2006 The enigmatic epidemiology of nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 15 10 1765 1777 10.1158/1055-9965. EPI-06-0353 1:CAS:528:DC%2BD28XhtVGktbvL 17035381
13. SC Clute, et al. 2005 Cross-reactive influenza virus-specific CD8 T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis J Clin Invest 115 12 3602 3612 10.1172/JCI25078 1:CAS:528:DC%2BD2MXhtlSqtLjP 16308574
14. PL De Jager, et al. 2008 Integrating risk factors: HLA-DRB1 1501 and Epstein-Barr virus in multiple sclerosis Neurology 70 13 Pt 2 1113 1118 18272866
15. GN DeLorenze, et al. 2006 Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Arch Neurol 63 6 839 844 10.1001/archneur.63.6.noc50328 16606758
16. GC Ebers, et al. 1995 A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group Nature 377 6545 150 151 10.1038/377150a0 1:CAS:528:DyaK2MXotVOhtLw%3D 7675080
17. RA Farrell, et al. 2009 Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI Neurology 73 1 32 38 10.1212/WNL.0b013e3181aa29fe 1:CAS:528:DC%2BD1MXnsFyjtbg%3D 19458321
18. BJ Feng, et al. 2007 Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries Int J Cancer 121 7 1550 1555 10.1002/ijc.22813 1:CAS:528:DC%2BD2sXhtVSns7%2FF 17582611
19. JE Friedman, et al. 2005 A randomized clinical trial of valacyclovir in multiple sclerosis Mult Scler 11 3 286 295 10.1191/1352458505ms1185oa 1:CAS:528:DC%2BD2MXlslKntLk%3D 15957509
20. CR Gale CN Martyn 1995 Migrant studies in multiple sclerosis Prog Neurobiol 47 425 448 10.1016/0301-0082(95)00033-X 1:STN:280:DyaK28vgt1yjtg%3D%3D 8966212
21. JW Gratama I Ernberg 1995 Molecular epidemiology of Epstein-Barr virus infection Adv Cancer Res 67 197 255 10.1016/S0065-230X(08)60714-9 1:CAS:528:DyaK28Xktlejsw%3D%3D 8571815
22. F Gronen, et al. 2006 Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls J Neuroimmunol 180 1-2 185 192 10.1016/j.jneuroim.2006.08.008 1:CAS:528:DC%2BD28Xht1SmsLzO 17023054
23. SL Hauser, et al. 2008 B-cell depletion with rituximab in relapsing-remitting multiple sclerosis N Engl J Med 358 7 676 688 10.1056/NEJMoa0706383 1:CAS:528:DC%2BD1cXhvVehtb0%3D 18272891
24. H Hjalgrim, et al. 2003 Characteristics of Hodgkin's lymphoma after infectious mononucleosis N Engl J Med 349 14 1324 1332 10.1056/NEJMoa023141 1:CAS:528:DC%2BD3sXnvVGit7g%3D 14523140
25. P Hollsberg, et al. 2003 Altered CD8+T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis Clin Exp Immunol 132 137 143 10.1046/j.1365-2249.2003.02114.x 1:CAS:528:DC%2BD3sXjtlKrsLg%3D 12653848
26. T Holmoy, et al. 2004 Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein J Neurovirology 10 5 278 283 10.1080/13550280490499524 1:CAS:528: DC%2BD2cXnslSnu70%3D
27. D Iwakiri, et al. 2009 Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3 J Exp Med 206 10 2091 2099 10.1084/jem.20081761 1:CAS:528:DC%2BD1MXht1SrtbvF 19720839
28. S Jilek, et al. 2008 Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis Brain 131 Pt 7 1712 1721 10.1093/brain/awn108 18550621
29. Kieff ED, Rickinson AB (2007) Epstein-Barr virus and its replication. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 2603-2654
30. SK Kim, et al. 2005 Private specificities of CD8 T cell responses control patterns of heterologous immunity J Exp Med 201 4 523 533 10.1084/jem.20041337 1:CAS:528:DC%2BD2MXhs1KmsLg%3D 15710651
31. JF Kurtzke A Heltberg 2001 Multiple sclerosis in the Faroe Islands: an epitome J Clin Epidemiol 54 1 1 22 10.1016/S0895-4356(00)00268-7 1:STN:280:DC%2BD3M7lsFaltg%3D%3D 11165464
32. JL Kutok F Wang 2006 Spectrum of Epstein-Barr virus-associated diseases Annu Rev Pathol 1 375 404 10.1146/annurev.pathol.1.110304.100209 1:CAS:528:DC%2BD28XktVOiurw%3D 18039120
33. HL Lang, et al. 2002 A functional and structural basis for TCR cross-reactivity in multiple sclerosis Nat Immunol 3 10 940 943 10.1038/ni835 1:CAS:528:DC%2BD38XnsVGrs7Y%3D 12244309
34. LI Levin, et al. 2005 Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis JAMA 293 20 2496 2500 10.1001/jama.293.20.2496 1:CAS:528:DC%2BD2MXksFWktrw%3D 15914750
35. Levin LI et al (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. doi: 10.1002/ana.21978
36. JW Lindsey, et al. 2008 Epstein-Barr virus genotypes in multiple sclerosis Acta Neurol Scand 117 2 141 144 1:CAS:528:DC%2BD1cXivFGrtbo%3D 18184350
37. JD Lunemann, et al. 2006 Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis Brain 129 Pt 6 1493 1506 10.1093/brain/awl067 16569670
38. JD Lunemann, et al. 2008 EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-{gamma} and IL-2 J Exp Med 205 8 1763 1773 10.1084/jem.20072397 1:CAS:528: DC%2BD1cXpsFOjsrY%3D 18663124
39. J Lycke, et al. 1996 Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study J Neurol 243 214 224 10.1007/BF00868517 1:STN:280:DyaK2s%2FptVCnsA%3D%3D 8936350
40. J Massa, et al. 2007 Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis Neuroepidemiology 28 4 214 215 10.1159/000108113 1:STN:280:DC%2BD2snhtVSgsw%3D%3D 17851260
41. M Melbye, et al. 1984 Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma Int J Cancer 34 619 623 10.1002/ijc.2910340506 1:STN:280:DyaL2M%2FltlGltA%3D%3D 6094363
42. AM Moormann, et al. 2007 Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in kenyan children J Infect Dis 195 6 799 808 10.1086/511984 1:CAS:528: DC%2BD2sXjvVSisr4%3D 17299709
43. M Moutschen, et al. 2007 Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults Vaccine 25 24 4697 4705 10.1016/j.vaccine.2007.04.008 1:CAS:528:DC%2BD2sXlsF2ltrw%3D 17485150
44. M Munch, et al. 1998 A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters Acta Neurol Scand 98 395 399 10.1111/j.1600-0404. 1998.tb07320.x 1:STN:280:DyaK1M%2FptVOqtw%3D%3D 9875617
45. KL Munger, et al. 2004 Vitamin D intake and incidence of multiple sclerosis Neurology 62 60 65 1:CAS:528:DC%2BD3sXhtVWjtrrP 14718698
46. KL Munger, et al. 2006 Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 23 2832 2838 10.1001/jama.296.23.2832 1:CAS:528:DC%2BD28XhtlCqtL3J 17179460
47. TR Nielsen, et al. 2007 Multiple sclerosis after infectious mononucleosis Arch Neurol 64 1 72 75 10.1001/archneur.64.1.72 17210811
48. Peferoen LA et al (2009) Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain. doi: 10.1093/brain/awp296
49. MP Pender 2003 Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases Trends Immunol 24 11 584 588 10.1016/j.it.2003.09. 005 1:CAS:528:DC%2BD3sXosVyis7o%3D 14596882
50. MP Pender, et al. 2009 Decreased T-cell reactivity to Epstein-Barr virus-infected lymphoblastoid cell lines in multiple sclerosis J Neurol Neurosurg Psychiatry 80 5 498 505 10.1136/jnnp.2008.161018 1:STN:280: DC%2BD1M3otVOgsw%3D%3D 19015225
51. D Pohl, et al. 2006 High seroprevalence of Epstein-Barr virus in children with multiple sclerosis Neurology 67 11 2063 2065 10.1212/01.wnl.0000247665. 94088.8d 1:STN:280:DC%2BD28jit1Krsg%3D%3D 17159123
52. SV Ramagopalan, et al. 2009 Association of infectious mononucleosis with multiple sclerosis. A population-based study Neuroepidemiology 32 4 257 262 10.1159/000201564 19209005
53. KH Rand, et al. 2000 Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis J Neurol Sci 173 1 32 39 10.1016/S0022-510X(99)00298-1 1:CAS:528:DC%2BD3cXpsFyjsQ%3D%3D 10675577
54. Rickinson AB, Kieff E (2007) Epstein-Barr virus. In: Knipe DM et al (eds) Fields virology, vol 2, 5th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 2655-2700
55. M Rowe, et al. 2009 Burkitt's lymphoma: the rosetta stone deciphering Epstein-Barr virus biology Semin Cancer Biol 19 6 377 388 10.1016/j.semcancer. 2009.07.004 19619657
56. Sargsyan SA et al (2010) Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. doi: 10.1212/WNL. 0b013e3181d865a1
57. B Serafini, et al. 2007 Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain J Exp Med 204 12 2899 2912 10.1084/jem.20071030 1:CAS:528:DC%2BD2sXhsVSgs7rP 17984305
58. KC Simon, et al. 2007 Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis Mult Scler 13 7 947 948 10.1177/1352458506072983 17881405
59. EM Sokal, et al. 2007 Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults J Infect Dis 196 12 1749 1753 10.1086/523813 18190254
60. P Sundstrom, et al. 2004 An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study Neurology 62 12 2277 2282 1:STN:280:DC%2BD2czgvFaqtw%3D%3D 15210894
61. N Sutkowski, et al. 2001 Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen Immunity 15 4 579 589 10.1016/S1074-7613(01)00210-2 1:CAS:528:DC%2BD3MXotVegtLk%3D 11672540
62. A Tai, et al. 2008 Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis Mult Scler 14 9 1175 1180 10.1177/1352458508094641 1:CAS:528:DC%2BD1MXhslWjtw%3D%3D 18701576
63. K Takeuchi, et al. 2006 Prevalence of Epstein-Barr virus in Japan: trends and future prediction Pathol Int 56 3 112 116 10.1111/j.1440-1827.2006.01936.x 16497243
64. EL Thacker, et al. 2006 Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis Ann Neurol 59 3 499 503 10.1002/ana.20820 16502434
65. DA Thorley-Lawson 2001 Epstein-Barr virus: exploiting the immune system Nat Rev Immunol 1 1 75 82 10.1038/35095584 1:CAS:528:DC%2BD38XlvF2qtb8%3D 11905817
66. AC van Sechel, et al. 1999 EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis J Immunol 162 1 129 135 9886378
67. JH Vaughn, et al. 1996 An Epstein-Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway J Neuroimmunol 69 95 102 10.1016/0165-5728(96)00069-0
68. H-J Wagner, et al. 2004 Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis Eur J Neurol 11 833 834 10.1111/j.1468-1331.2004.00871.x 15667414
69. K Wandinger, et al. 2000 Association between clinical disease activity and Epstein-Barr virus reactivation in MS Neurology 55 2 178 184 1:STN:280:DC%2BD3czpvValug%3D%3D 10908887
70. HB Warner RI Carp 1981 Multiple sclerosis and Epstein-Barr virus (letter) Lancet 2 1290 10.1016/S0140-6736(81)91527-0 1:STN:280:DyaL38%2FnvFOjsA%3D%3D 6118702
71. SN Willis, et al. 2009 Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain Brain 132 Pt 12 3318 3328 10.1093/brain/awp200 19638446
72. BM Zaadstra, et al. 2008 Selective association of multiple sclerosis with infectious mononucleosis Mult Scler 14 3 307 313 10.1177/1352458507084265 1:STN:280:DC%2BD1c3lslymuw%3D%3D 18208871
73. R Zivadinov, et al. 2009 Epstein-Barr Virus is associated with gray matter atrophy in multiple sclerosis J Neurol Neurosurg Psychiatry 80 6 620 625 10.1136/jnnp.2008.154906 1:STN:280:DC%2BD1Mzkslyruw%3D%3D 19168469